Latest On Exagen Inc (XGN):
About Exagen Inc (XGN):
Exagen Inc. develops and commercializes various testing products based on its Cell-Bound Complement Activation Products technology under the AVISE brand in the United States. It enable rheumatologists to enhance care for patients through the diagnosis, prognosis, and monitoring of complex autoimmune and autoimmune related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company's products also comprise AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of eight autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE SLE Prognostic, a ten-biomarker panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; AVISE Anti-CarP test, which identifies RA patients with severe disease requiring aggressive therapy, such as anti-TNF biologics; and AVISE PC4d that measures platelet- bound C4d. Further, the company offers AVISE SLE Monitor, a six-biomarker blood test; AVISE MTX, a patented and validated blood test that measures levels of MTXPG; and AVISE HCQ, a blood test designed to help rheumatologists objectively monitor levels of hydroxychloroquine. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.
General
- Name Exagen Inc
- Symbol XGN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 153
- Fiscal Year EndDecember
- IPO Date2019-09-19
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Providers & Services
- Web URLhttp://www.exagen.com
Valuation
- Trailing PE 0.38
- Price/Sales (Trailing 12 Mt.) 7.03
- Price/Book (Most Recent Quarter) 6.27
- Enterprise Value Revenue 5.81
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.62
- Next Year EPS Estimate -$1.71
- Next Quarter EPS Estimate -$0.39
- Profit Margin -40%
- Operating Margin -36%
- Return on Assets -11%
- Return on Equity -34%
- Revenue 41.98 million
- Earnings Per Share -$293.37
- Revenue Per Share $3.32
- Gross Profit 25.42 million
- Quarterly Earnings Growth 24%
Highlights
- Market Capitalization 260.49 million
- EBITDA -4852000
- PE Ratio -2.99
- Analyst Target Price $27
- Book Value Per Share $4.67
Share Statistics
- Shares Outstanding 12.67 million
- Shares Float 4.2 million
- % Held by Insiders 3140%
- % Held by Institutions 60.02%
- Shares Short 127728
- Shares Short Prior Month 122672
- Short Ratio 5.83
- Short % of Float 2%
- Short % of Shares Outstanding 1%
Technicals
- 52 Week High $23.18
- 52 Week Low $10.29
- 50 Day Moving Average 18.77
- 200 Day Moving Average 15.15
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Exagen Inc (XGN) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Exagen Inc (XGN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2020-12-31 | $N/A | -$0.27 | -$0.40 | 32.5% |
2020-09-30 | 2020-11-10 | $N/A | -$0.34 | -$0.47 | 28.27% |
2020-06-30 | 2020-07-28 | $8.95 million | -$0.27 | -$0.80 | 66.04% |
2020-03-31 | 2020-05-11 | $9.58 million | -$0.44 | -$0.57 | 22.12% |
2019-12-31 | 2020-03-25 | $10.21 million | -$0.27 | -$0.37 | 26.37% |
2019-09-30 | 2019-11-12 | $10.44 million | -$11.29 | -$2.40 | -370.42% |
Exagen Inc (XGN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Exagen Inc (XGN) Chart:
Exagen Inc (XGN) News:
Below you will find a list of latest news for Exagen Inc (XGN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Exagen Inc (XGN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2025-04-17 | 2.5 | 1.55 | CALL | 0 | 22 | 444.56 | TRUE | 0 | 0 |
2025-04-17 | 5 | 0.1 | CALL | 0 | 40 | 126.69 | FALSE | 0 | 0 |
2025-04-17 | 7.5 | 0.2 | CALL | 0 | 1 | 811.6 | FALSE | 0 | 0 |
2025-04-17 | 10 | 0 | CALL | 0 | 0 | 880.12 | FALSE | 0 | 0 |
2025-04-17 | 2.5 | 0.05 | PUT | 0 | 259 | 148.44 | FALSE | 0 | 0 |
2025-04-17 | 5 | 1.4 | PUT | 0 | 32 | 126.33 | TRUE | 0 | 0 |
2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 182.32 | TRUE | 0 | 0 |
2025-04-17 | 10 | 0 | PUT | 0 | 0 | 434.34 | TRUE | 0 | 0 |
2025-05-16 | 2.5 | 0 | CALL | 0 | 0 | 320.73 | TRUE | 0 | 0 |
2025-05-16 | 5 | 0 | CALL | 0 | 0 | 167.35 | FALSE | 0 | 0 |
2025-05-16 | 7.5 | 0 | CALL | 0 | 0 | 553.72 | FALSE | 0 | 0 |
2025-05-16 | 2.5 | 0 | PUT | 0 | 0 | 357.61 | FALSE | 0 | 0 |
2025-05-16 | 5 | 1.35 | PUT | 0 | 1 | 108.92 | TRUE | 0 | 0 |
2025-05-16 | 7.5 | 0 | PUT | 0 | 0 | 212.09 | TRUE | 0 | 0 |
2025-07-18 | 2.5 | 1.8 | CALL | 0 | 5 | 278 | TRUE | 0 | 0 |
2025-07-18 | 5 | 0.55 | CALL | 0 | 60 | 106.04 | FALSE | 0 | 0 |
2025-07-18 | 7.5 | 0.18 | CALL | 0 | 26 | 101.93 | FALSE | 0 | 0 |
2025-07-18 | 10 | 0 | CALL | 0 | 0 | 429.41 | FALSE | 0 | 0 |
2025-07-18 | 2.5 | 0.6 | PUT | 0 | 21 | 115.31 | FALSE | 0 | 0 |
2025-07-18 | 5 | 2.02 | PUT | 0 | 86 | 99.39 | TRUE | 0 | 0 |
2025-07-18 | 7.5 | 0 | PUT | 0 | 0 | 122.96 | TRUE | 0 | 0 |
2025-07-18 | 10 | 0 | PUT | 0 | 0 | 291.27 | TRUE | 0 | 0 |
2025-10-17 | 2.5 | 1.85 | CALL | 0 | 8 | 204.83 | TRUE | 0 | 0 |
2025-10-17 | 5 | 0.85 | CALL | 0 | 7 | 259.81 | FALSE | 0 | 0 |
2025-10-17 | 7.5 | 0.4 | CALL | 0 | 22 | 114.09 | FALSE | 0 | 0 |
2025-10-17 | 2.5 | 0 | PUT | 0 | 0 | 289.65 | FALSE | 0 | 0 |
2025-10-17 | 5 | 1.4 | PUT | 27 | 25 | 102.78 | TRUE | 1.4 | 0 |
2025-10-17 | 7.5 | 0 | PUT | 0 | 0 | 95.49 | TRUE | 0 | 0 |
Latest XGN Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 15 | $6.19 |
Jun 13, 2022 7:59 PM EST | 3 | $6.19 |
Jun 13, 2022 7:59 PM EST | 6 | $6.15 |
Jun 13, 2022 7:59 PM EST | 16 | $6.15 |
Jun 13, 2022 7:59 PM EST | 51 | $6.14 |
Exagen Inc (XGN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000066/0001274737-20-000066-index.htm |
2019-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319023893/0000899243-19-023893-index.htm |
2019-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319023895/0000899243-19-023895-index.htm |
2019-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319023897/0000899243-19-023897-index.htm |
2019-09-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319023899/0000899243-19-023899-index.htm |
2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024008/0000899243-19-024008-index.htm |
2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024012/0000899243-19-024012-index.htm |
2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024013/0000899243-19-024013-index.htm |
2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024016/0000899243-19-024016-index.htm |
2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024017/0000899243-19-024017-index.htm |
2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024019/0000899243-19-024019-index.htm |
2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024078/0000899243-19-024078-index.htm |
2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024081/0000899243-19-024081-index.htm |
2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024082/0000899243-19-024082-index.htm |
2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024083/0000899243-19-024083-index.htm |
2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024084/0000899243-19-024084-index.htm |
2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024086/0000899243-19-024086-index.htm |
2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1274737/000095014220000328/0000950142-20-000328-index.htm |
2020-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000095014220001148/0000950142-20-001148-index.htm |
2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1274737/000110465920021727/0001104659-20-021727-index.htm |
2020-09-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1274737/000114036120020885/0001140361-20-020885-index.htm |
2019-09-20 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1274737/000119312519250698/0001193125-19-250698-index.htm |
2019-09-20 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1274737/000119312519250784/0001193125-19-250784-index.htm |
2019-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000119312519252366/0001193125-19-252366-index.htm |
2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120021042/0001209191-20-021042-index.htm |
2020-03-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120021043/0001209191-20-021043-index.htm |
2020-03-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120021339/0001209191-20-021339-index.htm |
2020-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120021345/0001209191-20-021345-index.htm |
2020-03-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120021486/0001209191-20-021486-index.htm |
2020-04-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120024575/0001209191-20-024575-index.htm |
2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120031883/0001209191-20-031883-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120032932/0001209191-20-032932-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120036167/0001209191-20-036167-index.htm |
2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120047275/0001209191-20-047275-index.htm |
2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120049452/0001209191-20-049452-index.htm |
2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120050352/0001209191-20-050352-index.htm |
2020-10-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000120919120055322/0001209191-20-055322-index.htm |
2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000009/0001274737-20-000009-index.htm |
2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000012/0001274737-20-000012-index.htm |
2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000013/0001274737-20-000013-index.htm |
2020-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000016/0001274737-20-000016-index.htm |
2020-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000024/0001274737-20-000024-index.htm |
2020-03-25 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000026/0001274737-20-000026-index.htm |
2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000031/0001274737-20-000031-index.htm |
2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000032/0001274737-20-000032-index.htm |
2020-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000036/0001274737-20-000036-index.htm |
2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000037/0001274737-20-000037-index.htm |
2020-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000040/0001274737-20-000040-index.htm |
2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000043/0001274737-20-000043-index.htm |
2020-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000044/0001274737-20-000044-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000061/0001274737-20-000061-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000062/0001274737-20-000062-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000063/0001274737-20-000063-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000064/0001274737-20-000064-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000065/0001274737-20-000065-index.htm |
2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000066/0001274737-20-000066-index.htm |
2020-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000070/0001274737-20-000070-index.htm |
2020-07-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000074/0001274737-20-000074-index.htm |
2020-07-28 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000077/0001274737-20-000077-index.htm |
2020-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000080/0001274737-20-000080-index.htm |
2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000087/0001274737-20-000087-index.htm |
2020-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1274737/000127473720000088/0001274737-20-000088-index.htm |
2020-01-27 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1274737/000149315220001141/0001493152-20-001141-index.htm |
2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000162828019013993/0001628280-19-013993-index.htm |
2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1274737/000162828019014001/0001628280-19-014001-index.htm |
2019-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000162828019014376/0001628280-19-014376-index.htm |
2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1274737/000162828019014462/0001628280-19-014462-index.htm |
2019-09-18 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1274737/999999999519002124/9999999995-19-002124-index.htm |
Exagen Inc (XGN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exagen Inc (XGN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 3140%Institutional Ownership: 6002%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-03-11 | EBETUEL PALLARES | Director | Buy | 22,427.00 | 1.84 | 41,265.68 | 144,094.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120021486/0001209191-20-021486-index.htm |
2020-03-11 | EBETUEL PALLARES | Director | Buy | 2,265.00 | 1.84 | 4,167.60 | 144,247.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120021486/0001209191-20-021486-index.htm |
2020-09-11 | JAMES L L TULLIS | Director | Sell | 15,000.00 | 12.40 | 186,000.00 | 1,585,275.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120050352/0001209191-20-050352-index.htm |
2020-08-18 | JAMES L L TULLIS | Director | Sell | 2,082.00 | 14.52 | 30,221.06 | 1,600,275.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120047275/0001209191-20-047275-index.htm |
2020-08-14 | JAMES L L TULLIS | Director | Sell | 11,507.00 | 16.95 | 195,051.70 | 1,602,357.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120047275/0001209191-20-047275-index.htm |
2020-06-09 | JAMES L L TULLIS | Director | Sell | 4,782.00 | 12.91 | 61,735.14 | 1,613,864.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120036167/0001209191-20-036167-index.htm |
2020-06-09 | JAMES L L TULLIS | Director | Sell | 1,522.00 | 12.77 | 19,439.90 | 1,618,646.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120036167/0001209191-20-036167-index.htm |
2020-05-28 | JAMES L L TULLIS | Director | Sell | 2,240.00 | 11.93 | 26,723.87 | 1,620,168.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120032932/0001209191-20-032932-index.htm |
2020-05-27 | JAMES L L TULLIS | Director | Sell | 1,595.00 | 12.57 | 20,054.89 | 1,622,408.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120032932/0001209191-20-032932-index.htm |
2019-09-23 | H.I.G. Bio-Exagen, L.P. | 10% Share Holder | Buy | 425,000.00 | 14.00 | 5,950,000.00 | 1,696,252.00 | https://www.sec.gov/Archives/edgar/data/1274737/000089924319024078/0000899243-19-024078-index.htm |
2020-09-01 | NMSIC Co-Investment Fund, L.P. | 10% Share Holder | Sell | 126,404.00 | 12.50 | 1,580,050.00 | 2,433,958.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120049452/0001209191-20-049452-index.htm |
2020-10-19 | JAMES L L TULLIS | Director | Sell | 198.00 | 16.02 | 3,171.07 | 32,127.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120055322/0001209191-20-055322-index.htm |
2020-10-16 | JAMES L L TULLIS | Director | Sell | 2,104.00 | 16.25 | 34,180.32 | 32,325.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120055322/0001209191-20-055322-index.htm |
2020-10-15 | JAMES L L TULLIS | Director | Sell | 4,316.00 | 14.88 | 64,225.96 | 34,429.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120055322/0001209191-20-055322-index.htm |
2020-08-14 | JAMES L L TULLIS | Director | Sell | 1,398.00 | 16.95 | 23,697.08 | 38,745.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120047275/0001209191-20-047275-index.htm |
2020-06-09 | JAMES L L TULLIS | Director | Sell | 578.00 | 12.77 | 7,382.56 | 40,143.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120036167/0001209191-20-036167-index.htm |
2020-05-28 | JAMES L L TULLIS | Director | Sell | 848.00 | 11.93 | 10,116.89 | 40,721.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120032932/0001209191-20-032932-index.htm |
2020-05-27 | JAMES L L TULLIS | Director | Sell | 605.00 | 12.57 | 7,607.03 | 41,569.00 | https://www.sec.gov/Archives/edgar/data/1274737/000120919120032932/0001209191-20-032932-index.htm |